Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • firefly2280
    Member
    • Oct 2012
    • 28

    #1

    Bacterial Transcriptome sample prep following different doses of drug

    Dear all

    If we wanted to look at bacterial transcriptomes and how they differ following exposure to different doses of a drug, how important isi t to keep the bacterial population the same? I mean, if they are exposed to a low concentration, they will grow more but a higher concentration they will grow less. I know you normalise RNA before sequencing but I read you should keep the OD of the culute the same throughout.

    It will only be a max of 1 hr, so Im not sure the OD would change too much anyway.

    any thoughts?

    thanks
  • kwaraska
    Senior Member
    • Nov 2008
    • 131

    #2
    We always normalize based on total RNA. The transcript population will vary but will be proportional. Keeping the OD of the culture is less important(in my opinion) than starting with equal total RNA

    Comment

    • buthercup_ch
      Member
      • Apr 2014
      • 41

      #3
      What is the meaning of "keep the OD of the culture the same throughout"?

      You are going to study the differential expression between control and treated samples, right? Then of course bacteria will behave differently depending if they are treated or not.
      What is important for transcriptomics is to use high quality RNA samples as starters. Normally 0.5-4 micrograms of total RNA is enough to work with, but I recommend to obtain as much as you can to ensure you will have enough for all QC and further validation of your differential expression results.
      For that, the only thing you have to do is standardize the amount of bacteria you have to harvest to proceed with RNA extraction, and in this regard, yes, to keep a "total" OD of your samples is helpful. It means, harvest the same a mount of bacteria treated or untreated.

      Hope this will help

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      38 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      28 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      41 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      45 views
      0 reactions
      Last Post SEQadmin2  
      Working...